疾病风险预测的实用方法:通过最高k损失专注于高风险患者
Hongyi Yang1,2,3, Rich Gonzalez4, Brahmajee K Nallamothu5,3
1Department of Electrical Engineering and Computer Science, University of Michigan, Ann Arbor, MI, USA.
概括
本研究介绍了Highest-k Loss,这是一种通过专注于高风险患者和减少假阳性来改善疾病风险预测的新方法. 这种实用方法提高了确定最有可能从干预中受益的个体的精度.
科学领域:
- 医疗保健人工智能和机器学习
- 医学中的预测分析.
- 计算健康科学 计算健康科学
背景情况:
- 疾病风险预测模型对于积极主动的医疗保健至关重要,但由于高风险患者随访的资源限制,在实际应用方面存在困难.
- 现有的模型往往无法充分应对高风险个体中最小化虚假阳性的挑战,影响资源配置和干预效率.
研究的目的:
- 提出一种新而实用的方法,Highest-k Loss,通过最大限度地减少高风险患者群体内的虚假阳性来提高疾病风险预测.
- 开发一种方法,优先考虑具有最高预测分数的患者的干预,优化有限的医疗资源的使用.
主要方法:
- 引入了Highest-k Loss函数,该函数使用可微分排序操作估计最高预测分数的权重.
- 将Highest-k Loss应用于糖尿病预测任务,使用来自美国健康调查的大量数据集 (253,680个响应).
- 使用嵌套交叉验证和在独立测试组上的聚合模型进行严格评估.
主要成果:
- 与传统的二进制交叉和焦点损失相比,最高k损失显著提高了预测分数的前1%,5%和10%的精度 (正预测值).
- 具体的精度改进包括最高1%的0.05 (95%CI:0.041-0.055),最高5%的0.03 (95%CI:0.024-0.032) 和最高10%的0.02 (95%CI:0.016-0.021).
- 展示了风险预测的实用解决方案,该解决方案专注于可操作的患者队列,而不是整个人口.
结论:
- 最高k损失函数为当前疾病风险预测模型的关键局限性提供了实用和有效的解决方案.
- 这种方法提高了识别和专注于真正高风险患者的能力,从而优化医疗保健资源配置和干预策略.
- 该方法为改善预测模型在临床环境中的实际应用提供了宝贵的工具.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
112
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
112
Sensitivity, Specificity, and Predicted Value
165
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
165
Actuarial Approach
54
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
54
Levels of Health Promotion and Illness Prevention
11.5K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
11.5K
Preventive Healthcare Services
960
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
960
Hazard Ratio
77
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
77


